1 Raw soya flour (RSF) in the diet induces pancreatic hypertrophy and hyperplasia in the rat, changes ascribed to production of a high circulating level of cholecystokinin (CCK) due to inhibition of trypsin in the duodenum. Prolonged ingestion results in pancreatic adenomas and carcinomas.
2 L-364, 718, a potent, highly specific CCK antagonist was used to investigate the short-term role of CCK.
3 In rats fed 50% RSF and L-364, 718 5 mg kg-1 p.o. twice daily for 4 d, there was inhibition of pancreatic hypertrophy and hyperplasia, which is further evidence that peripherally-acting CCK plays a major role in the generation of RSF-mediated changes in the pancreas.
Get full access to this article
View all access options for this article.
References
1.
Booth AN, Robbins DJ, Ribelin WE et al. Effects of raw soya bean meal and amino acids on pancreatic hypertrophy in rats. Proceedings of the Society for Experimental Biology and Medicine1960; 104: 681-3.
2.
Oates PS & Morgan Rhg.Short-term effects of feeding raw soya flour on pancreatic cell turnover in the rat. American Journal of Physiology1984 ; 247: G667.
3.
Shingoethe DJ , Tidemann LJ & Uckert JRStudies in mice on the isolation and characterisation of growth inhibtols from soyabeans. Journal of Nutrition1974; 104: 1304-406.
4.
Kakade ML, Thompson RD, Engelst WE et al. Failure of soyabean trypsin inhibitor to exert deleterious effects in calves. Journal of Dairy Science1975; 59: 484-7.
5.
Applegarth A. , Furata F. & Lepkovsky S.Response of the chicken pancreas to raw soyabeans. Poultry Science1964; 43: 733-5.
6.
Yen JT, Hymowitz T. & Jensen AHEffects of soyabeans of different trypsin inhibitor activities on performance of growing swine. Journal of Animal Science1974; 38: 304-7
7.
Patten JR, Richards EA & Pope H.The effect of raw soyabean on the pancreas of adult dogs. Proceedings of the Society for Experimental Biology and Medicine1971; 37: 59-62.
8.
Tudor RJ & Dayan ADComparative sub-acute effects of dietary raw soya flour on the pancreas of three species, the marmoset, mouse and rat. Food and Chemical Toxicology1987; 10: 739-45.
9.
Folsch UR & Wormsley KGThe pancreatic secretion of enzymes in rats treated with soybean diet. Scandinavian Journal ofGastroenterology1974; 9: 679-83.
10.
'° Dijkhof J., Poort SR & Poort C.Effect of feeding soybean flour-containing diets on the protein synthesis pattern of the rat pancreas. Journal of Nutrition1977; 107: 1985-95.
11.
Crass RA & Morgan Rch.The effects of long-term feeding of soya-bean flour diets on pancreatic growth in the rat. British Journal of Nutrition1982 ; 47: 119-29.
12.
McGuiness EE & Morgan Rhg.Effects of soyabean flour on the pancreas of rats. Environmental Health Perspectives1984; 56: 205-12.
13.
Adrian TE, Pasquali C., Pescota F. et al. Soya-induced pancreatic hypertrophy and rise of circulating cholecystokinin (Abstract). Gut1982; 23: A889.
14.
Brand SJ & Morgan Rgh.The release of rat intestinal CCK after oral trypsin inhibitor measured by bioassay. Journal of Physiology1981; 319: 325-43.
15.
Rackis JJPhysiological properties of soyabean trypsin inhibitors and their relationship to pancreatic hypertrophy and growth inhibition of rats. Federation Proceedings1965; 24: 1488-93.
16.
Melmed RN, El-aaser Aaa & Holt SJHypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor. Biochemica et Biophysica Acta1976; 421: 280-8.
17.
Ihse I., Lilja P. & Lindquist I.Trypsin as a regulator of pancreatic secretion in the ratScandinavian Journal of Gastroenterology1979; 14: 873-80.
18.
Slaff JI, Wolfe MM & Toskes PPElevated fasting plasma cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation. Journal of Laboratory and Clinical Medicine1985; 105: 282-5.
19.
Folsch UR, Cantor P., Wilms HM et al. Role of CCK in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology1987; 92: 449-58.
20.
Lotti VJ, Pendleton RG, Gould RJ et al. In vivo pharmacology of L-364, 718, a new potent nonpeptide peripheral CCK antagonist. Journal of Pharmacology and Experimental Therapeutics1987; 241: 103-4.
21.
Wisner JR, McLaughlin RE, Rich KA et al. Effects of L-364, 718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology1988; 94: 109-13.
22.
Gibbs J. & Smith GPThe neuroendocrinology of postprandial satiety. In: Frontiers in Neuroendocrinology, eds Martini L. and Gangon W.F., Vol, 8, Chap. 7, pp. 223-45. New York: Raven Press , 1984.
23.
Chang Rsl, Lotti VJ, Monaghan RL et al. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus allicaceus. Science1985; 230: 177-9.
24.
Evans BE, Brock MG, Rittle KE et al. Design of potent, orally effective nonpeptidal antagonists of the peptide hormone cholecystokinin. Proceedings of the National Academy of Sciences USA1986; 83: 4918-22.
25.
Chang Rsl & Lotti VJBiochemical and pharmacological characterisation of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proceedings of the National Academy of Sciences USA1986; 83: 4923-6.
26.
Moran T., Robinson P., Goldrich M & McHugh PR. Two brain cholecystokinin receptors; implication for behavioural actions. Brain Research1986 ; 362: 175-9.
